4-88067950-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000297.4(PKD2):​c.2411G>A​(p.Ser804Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000532 in 1,614,094 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0026 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 2 hom. )

Consequence

PKD2
NM_000297.4 missense

Scores

3
7
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:7

Conservation

PhyloP100: 9.31

Publications

5 publications found
Variant links:
Genes affected
PKD2 (HGNC:9009): (polycystin 2, transient receptor potential cation channel) This gene encodes a member of the polycystin protein family. The encoded protein is a multi-pass membrane protein that functions as a calcium permeable cation channel, and is involved in calcium transport and calcium signaling in renal epithelial cells. This protein interacts with polycystin 1, and they may be partners in a common signaling cascade involved in tubular morphogenesis. Mutations in this gene are associated with autosomal dominant polycystic kidney disease type 2. [provided by RefSeq, Mar 2011]
PKD2 Gene-Disease associations (from GenCC):
  • autosomal dominant polycystic kidney disease
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • polycystic kidney disease 2
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000297.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010641098).
BP6
Variant 4-88067950-G-A is Benign according to our data. Variant chr4-88067950-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 289403.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00263 (400/152294) while in subpopulation AFR AF = 0.00816 (339/41556). AF 95% confidence interval is 0.00744. There are 3 homozygotes in GnomAd4. There are 208 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000297.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD2
NM_000297.4
MANE Select
c.2411G>Ap.Ser804Asn
missense
Exon 13 of 15NP_000288.1Q13563-1
PKD2
NM_001440544.1
c.2186G>Ap.Ser729Asn
missense
Exon 12 of 14NP_001427473.1
PKD2
NR_156488.2
n.2389G>A
non_coding_transcript_exon
Exon 12 of 14

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKD2
ENST00000237596.7
TSL:1 MANE Select
c.2411G>Ap.Ser804Asn
missense
Exon 13 of 15ENSP00000237596.2Q13563-1
PKD2
ENST00000927447.1
c.2408G>Ap.Ser803Asn
missense
Exon 13 of 15ENSP00000597506.1
PKD2
ENST00000927448.1
c.2312G>Ap.Ser771Asn
missense
Exon 12 of 14ENSP00000597507.1

Frequencies

GnomAD3 genomes
AF:
0.00263
AC:
400
AN:
152176
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00818
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00478
GnomAD2 exomes
AF:
0.000848
AC:
213
AN:
251112
AF XY:
0.000737
show subpopulations
Gnomad AFR exome
AF:
0.00720
Gnomad AMR exome
AF:
0.00188
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000167
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.000313
AC:
458
AN:
1461800
Hom.:
2
Cov.:
32
AF XY:
0.000296
AC XY:
215
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.00624
AC:
209
AN:
33476
American (AMR)
AF:
0.00199
AC:
89
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53410
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000827
AC:
92
AN:
1111960
Other (OTH)
AF:
0.00101
AC:
61
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00263
AC:
400
AN:
152294
Hom.:
3
Cov.:
32
AF XY:
0.00279
AC XY:
208
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00816
AC:
339
AN:
41556
American (AMR)
AF:
0.00275
AC:
42
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68024
Other (OTH)
AF:
0.00473
AC:
10
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000875
Hom.:
1
Bravo
AF:
0.00297
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
2
not provided (5)
-
-
3
not specified (3)
-
1
1
Polycystic kidney disease 2 (2)
-
-
1
Autosomal dominant polycystic kidney disease (1)
-
1
-
Polycystic kidney disease (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.43
T
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.037
D
MetaRNN
Benign
0.011
T
MetaSVM
Uncertain
-0.26
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
9.3
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-0.73
N
REVEL
Benign
0.24
Sift
Benign
0.082
T
Sift4G
Benign
0.19
T
Varity_R
0.18
gMVP
0.36
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs145343957;
hg19: chr4-88989102;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.